These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18391063)

  • 1. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
    Xu RH; Cohen M; Tang Y; Lazear E; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
    J Exp Med; 2008 Apr; 205(4):981-92. PubMed ID: 18391063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathogenesis and Immunobiology of Mousepox.
    Sigal LJ
    Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
    Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G
    PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
    Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
    J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.
    Melo-Silva CR; Tscharke DC; Lobigs M; Koskinen A; Wong YC; Buller RM; Müllbacher A; Regner M
    J Virol; 2011 Nov; 85(21):11170-82. PubMed ID: 21849445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
    Gratz MS; Suezer Y; Kremer M; Volz A; Majzoub M; Hanschmann KM; Kalinke U; Schwantes A; Sutter G
    J Virol; 2011 Apr; 85(7):3557-69. PubMed ID: 21270149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectromelia virus: the causative agent of mousepox.
    Esteban DJ; Buller RML
    J Gen Virol; 2005 Oct; 86(Pt 10):2645-2659. PubMed ID: 16186218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.
    Frey TR; Forsyth KS; Sheehan MM; De Haven BC; Pevarnik JG; Hand ES; Pizzorno MC; Eisenlohr LC; Hersperger AR
    Virology; 2018 May; 518():335-348. PubMed ID: 29602068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Pathogenesis, Genomics and Phylogeography of Mousepox.
    Mavian C; López-Bueno A; Martín R; Nitsche A; Alcamí A
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34203773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.
    Lynn H; Horsington J; Ter LK; Han S; Chew YL; Diefenbach RJ; Way M; Chaudhri G; Karupiah G; Newsome TP
    J Virol; 2012 Jul; 86(13):7427-43. PubMed ID: 22532690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox.
    Melo-Silva CR; Tscharke DC; Lobigs M; Koskinen A; Müllbacher A; Regner M
    Virus Res; 2017 Jan; 228():61-65. PubMed ID: 27865865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
    Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
    Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.
    Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A
    PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.
    Xu RH; Rubio D; Roscoe F; Krouse TE; Truckenmiller ME; Norbury CC; Hudson PN; Damon IK; Alcamí A; Sigal LJ
    PLoS Pathog; 2012 Jan; 8(1):e1002475. PubMed ID: 22241999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox.
    Chen N; Buller RM; Wall EM; Upton C
    Virus Res; 2000 Feb; 66(2):155-73. PubMed ID: 10725549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
    Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
    Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.
    Ma X; Xu RH; Roscoe F; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
    J Virol; 2013 Jun; 87(12):7046-53. PubMed ID: 23596297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.